Unsupported browser detected
Your browser appears to be unsupported. Because of this, portions of the site may not function as intended.
Please install a current version of Chrome, Firefox, Edge, or Safari for a better experience.
Purpose
to enhance our ability to quantitatively inform optimal dose of a novel long acting formulation of ivermectin
Grantee
Division
Global Health
Date
OCTOBER 2021
Region Served
GLOBAL,
EUROPE
Committed Amount
$126,126
Grant Topic
Malaria
Duration (Months)
12
Grantee Location
Oxford, Oxfordshire, United Kingdom
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.